# Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35

> **NCT00958321** · PHASE2 · TERMINATED · sponsor: **Cancer Trials Ireland** · enrollment: 40 (estimated)

## Conditions studied

- Lung Cancer
- Metastatic Cancer

## Interventions

- **PROCEDURE:** computed tomography
- **RADIATION:** 3-dimensional conformal radiation therapy
- **RADIATION:** fludeoxyglucose F 18
- **RADIATION:** radiation therapy treatment planning/simulation

## Key facts

- **NCT ID:** NCT00958321
- **Lead sponsor:** Cancer Trials Ireland
- **Sponsor class:** NETWORK
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-03
- **Primary completion:** 2016-12
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Why stopped:** Low levels of recruitment
- **Last updated:** 2017-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00958321

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00958321, "Positron Emission Tomography and Computed Tomography in Planning Treatment for Patients Undergoing 3-Dimensional Conformal Radiation Therapy for Non-Small Cell Lung Cancer That Cannot Be Removed by Surgery. ICORG 06-35". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00958321. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*